A 48-Week, Multicentre, Multinational, Randomized, Double-Blind, 2-Arm Parallel Group, Comparing the Efficacy of Foster for Maintenance and Reliever Versus Fixed-Dose Foster for Maintenance Plus Salbutamol as Reliever in Asthmatics > or = 18 Years of Age.

Trial Profile

A 48-Week, Multicentre, Multinational, Randomized, Double-Blind, 2-Arm Parallel Group, Comparing the Efficacy of Foster for Maintenance and Reliever Versus Fixed-Dose Foster for Maintenance Plus Salbutamol as Reliever in Asthmatics > or = 18 Years of Age.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Beclometasone/formoterol (Primary) ; Salbutamol
  • Indications Asthma
  • Focus Registrational; Therapeutic Use
  • Sponsors Chiesi Farmaceutici
  • Most Recent Events

    • 04 Apr 2017 Last checked against ClinicalTrials.gov record.
    • 21 Apr 2012 Planned number of patients changed from 2404 to 2482 as reported by European Clinical Trials Database.
    • 21 Apr 2012 Additional trial locations added as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top